Early Detection of Prostate Cancer
Publication Date: April 25, 2023
Last Updated: April 26, 2023
PSA Screening
Clinicians should engage in shared decision-making (SDM) with people for whom prostate cancer screening would be appropriate and proceed based on a person’s values and preferences. (Clinical Principle, )
322859
Initial Biopsy
Clinicians should inform patients undergoing a prostate biopsy that there is a risk of identifying a cancer with a sufficiently low risk of mortality that could safely be monitored with active surveillance (AS) rather than treated. (Clinical Principle, )
322859
Overview
Title
Early Detection of Prostate Cancer
Authoring Organizations
American Urological Association
Society of Urologic Oncology